News

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
CIDRAP20m
CDC estimates show jump in NB.1.8.1 COVID variant proportions
In other developments, the ECDC today reported a slow rise in COVID activity in the Europe, which may partly reflect waning ...
HHS Misleads on mRNA Vaccine Safety After Pulling Moderna Funding
The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety ...
FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
UCLA study: COVID vaccinations may lessen severe kidney damage
A new study from UCLA Health suggests COVID vaccines may protect patients from severe kidney damage. The study found ...
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
Rheumatology Advisor2d
FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.
FDA grants limited approval to new Covid vaccine from Moderna
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
KSL12d
FDA approves Moderna's next-generation COVID vaccine for adults 65 and older
The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...